NurseSavvy™
Log inSign Up

Endocrine · Topic 13 of 13

Diabetes Insipidus

Endocrine · water balance

Diabetes Insipidus

Large volumes of dilute urine with a rising sodium: replace free water, give desmopressin for central DI, and lower sodium no faster than 0.5 mEq/L per hour.

Key numbers
Dilute polyuria over 3 L/day> 3 L/day · Uosm < 300
Post-op DI: urine > 250 mL/h> 250 mL/h × 2 h
Central DI: give desmopressin, watch sodium2–4 mcg/day IV/SC
Lower sodium ≤ 0.5 mEq/L per hour≤ 0.5 mEq/L/h
01 · Defined byDilute polyuria over 3 L/day

DI = hypotonic polyuria: urine output > 3 L/day (or > 50 mL/kg/day) with urine osmolality < 300 mOsm/kg, often < 200 and specific gravity < 1.005; sodium climbs once water intake cannot keep up.

02 · Defined byPost-op DI: urine > 250 mL/h

After pituitary or hypothalamic surgery, urine output > 250 mL/h for 2 consecutive hours with urine osmolality < 300 mOsm/kg and a normal or high serum sodium is highly suggestive of central DI.

03 · GiveCentral DI: give desmopressin, watch sodium

Treat central DI with desmopressin — 2–4 mcg/day IV or SC in 1–2 doses in hospital, oral or intranasal long term — and monitor serum sodium, because overreplacement causes hyponatremia.

01

Causes & risk factors

Why it happens
Central causes: pituitary surgery, head trauma, tumorsCentral DI (AVP deficiency) follows hypothalamic-pituitary injury: transsphenoidal or hypothalamic surgery, head trauma (especially basal skull fracture), sellar and suprasellar tumors, infiltrative disease (sarcoidosis, Langerhans cell histiocytosis) and infection.
Nephrogenic causes: lithium, hypercalcemia, hypokalemiaNephrogenic DI (AVP resistance) is most often caused by lithium (40–55% of long-term users); also hypercalcemia, hypokalemia, demeclocycline, amphotericin B, obstruction, and X-linked V2-receptor mutations.
02

Do right now

In this order
First moves
1
Post-op DI: urine > 250 mL/h> 250 mL/h × 2 h
→
2
Exclude glucosuria, diuretics and post-op fluid diuresis
→
3
Replace free water; D5W if unable to drink
→
4
Central DI: give desmopressin, watch sodium2–4 mcg/day IV/SC
→
5
Lower sodium ≤ 0.5 mEq/L per hour≤ 0.5 mEq/L/h
Why each step
Post-op DI: urine > 250 mL/hAfter pituitary or hypothalamic surgery, urine output > 250 mL/h for 2 consecutive hours with urine osmolality < 300 mOsm/kg and a normal or high serum sodium is highly suggestive of central DI.
Exclude glucosuria, diuretics and post-op fluid diuresisBefore calling polyuria DI, exclude solute diuresis (hyperglycemia with glucosuria), diuretics including SGLT2 inhibitors, and excretion of excess intraoperative IV fluid: urine osmolality > 300 mOsm/kg suggests solute diuresis.
Replace free water; D5W if unable to drinkLet a patient with intact thirst drink to thirst; if thirst or access is impaired (sedation, altered mental status), replace the free-water deficit with IV D5W — half-normal saline can worsen hypernatremia in DI.
Central DI: give desmopressin, watch sodiumTreat central DI with desmopressin — 2–4 mcg/day IV or SC in 1–2 doses in hospital, oral or intranasal long term — and monitor serum sodium, because overreplacement causes hyponatremia.
Lower sodium ≤ 0.5 mEq/L per hourLower chronic or unknown-duration hypernatremia no faster than 0.5 mEq/L/h (at most 10–12 mEq/L per 24 h, over about 48 h) to avoid cerebral edema; acute (< 24 h) may be corrected within 24 h.
03

Management

Orders
Nephrogenic DI: thiazide and low-salt, low-protein dietTreat nephrogenic DI by stopping the cause (lithium) and correcting calcium and potassium, then a low-salt, low-protein diet plus a thiazide (hydrochlorothiazide 25 mg once or twice daily); NSAIDs or amiloride can add benefit.
Post-op: dose desmopressin as needed, not scheduledIn the first 2 weeks after pituitary surgery, give desmopressin only as needed for documented polyuria, with strict intake/output and frequent sodium checks; most postoperative DI is transient.
04

Red flags & don'ts

Avoid harm
Triphasic response: DI, then SIADH, then DI complicationAfter pituitary stalk injury: transient DI for days, then 2–14 days of antidiuresis from unregulated ADH release (hyponatremia), then permanent DI once ADH stores are depleted.
Desmopressin hyponatremia: allow a weekly aquaresis complicationDesmopressin carries a boxed warning for hyponatremia: check sodium within 1 week and at 1 month, and let outpatients delay or skip a dose weekly so excess water can be excreted.
05

Central or nephrogenic DI?

Commonly confused
ProblemToo little ADH released
Urine osmolality after desmopressinRises ≥ 50% (complete)
Classic causesPituitary surgery, head trauma, sellar tumors
TreatmentDesmopressin
06

Commonly confused

Tell apart
Standard desmopressin does not fix nephrogenic DIDesmopressin is the treatment for central DI but is not effective at usual doses in nephrogenic DI, where the collecting duct cannot respond to ADH.
Primary polydipsia concentrates urine when water-deprivedPrimary polydipsia usually has no nocturia, concentrates urine partly with water deprivation (about 500–600 mOsm/kg) and gains nothing from vasopressin; desmopressin is contraindicated in polydipsia because of hyponatremia risk.
07

More detail

Reference
Show 7 reference facts
Hypertonic saline–stimulated copeptin (serum sodium > 150 mEq/L) < 4.9 pmol/L indicates central DI rather than primary polydipsia; an unstimulated copeptin > 21.4 pmol/L indicates nephrogenic DI.
Stop the water deprivation test at orthostatic hypotension, ≥ 5% body-weight loss, or a urine osmolality plateau (< 30 mOsm/kg rise between samples); it needs constant supervision.
A 2022 international position statement renamed central DI arginine vasopressin deficiency (AVP-D) and nephrogenic DI arginine vasopressin resistance (AVP-R).
Adipsic DI (no thirst, classically after anterior communicating artery aneurysm repair) causes severe hypernatremia; manage with fixed desmopressin and a daily fluid intake set by daily weight.
Gestational DI: in late pregnancy the placenta secretes vasopressinase, which unmasks polyuria in patients with limited hypothalamic reserve.
About 50% of patients with transient postoperative DI recover within 7 days and 80% within 90 days of surgery.
Desmopressin injection is contraindicated with hyponatremia or a history of it, SIADH, polydipsia, creatinine clearance < 50 mL/min, heart failure or uncontrolled hypertension, and concurrent loop diuretics or systemic or inhaled glucocorticoids.
Pearl

Central DI answers desmopressin; nephrogenic DI ignores it.

Sources · Merck Manual Professional — Arginine Vasopressin Deficiency (Central Diabetes Insipidus) (full review Jun 2025) · Flynn K, Hatfield J et al. Central and nephrogenic diabetes insipidus: updates on diagnosis and management. Front Endocrinol 2024;15:1479764 (PMC11750692) · Merck Manual Professional — Hypernatremia · Almalki MH, Ahmad MM et al. Management of diabetes insipidus following surgery for pituitary and suprasellar tumours. Sultan Qaboos Univ Med J 2021;21:354–64 (PMC8407907) · DDAVP (desmopressin acetate) injection prescribing information — DailyMed · Merck Manual Professional — Arginine Vasopressin Resistance (Nephrogenic Diabetes Insipidus) · Evaluation and management of hypernatremia in adults: clinical perspectives. Korean J Intern Med 2023 (PMC10175862) · Starter sheet built from the verified AGACNP fact map (facts reviewed 2026-10-15).